PRESCIENT – PET ResponSe CrItEria for Neuroendocrine Tumors
Lisa Bodei, MD, PhD
Active Projects
Radiosensitizing NETs: a two-pronged approach using ERa and Pin1 inhibition
Xavier M. Keutgen, MD
Reconciling lung carcinoids histopathological and molecular classifications
Matthieu Foll, PhD
Role of CCL2 and IL-8 in Pituitary Neuroendocrine Tumor Microenvironment
Pedro Marques, MD, PhD
Single-Cell Proteomics of Pancreatic Neuroendocrine Tumors
Michael H. Roehrl, MD, PhD
Spatial transcriptomic profiling of the PanNET tumor microenvironment
Christopher Michael Heaphy, PhD
Targeted alpha therapy of NETs using somatostatin-based radiopharmaceuticals with improved tumor-to-kidney ratio, the theranostic approach.
Prof. Dr. Apr. Frederik Cleeren
Targeting Angiopoietin-2 to Improve ICI Therapy Efficacy in pNET Metastasis
Minah Kim, PhD
Targeting serotonin metabolism in SBNETs
Po Hien Ear, PhD
The role of the B7x pathway in the progression of NETs
Steven K Libutti, MD